- The FDA approves Roche's (OTCQX:RHHBY) HIV-1 viral load test for use on its automated cobas 6800 and 8800 systems. The diagnostic assay simultaneously amplifies and detects two separate regions of the HIV-1 genome which are not subject to selective drug pressure. The test will inform doctors on the effectiveness of antiretroviral therapy for their HIV-1 patients.
Roche's next generation HIV-1 test cleared for use on cobas systems
Recommended For You
More Trending News
About RHHBY Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
RHHBY | - | - |
Roche Holding AG |